CS-2631
|
|
- CAS号:
- 1433497-19-8
- 英文名:
- LY2955303
- 英文别名:
- CS-2631;LY2955303;LY2955303 >=98% (HPLC);LY2955303; LY-2955303; LY 2955303;inhibit,LY 2955303,Autophagy,LY-2955303,Retinoic acid receptors,RAR/RXR,Inhibitor,LY2955303,Retinoid X receptors;4-[5-[3,5-Bis(1,1-dimethylethyl)phenyl]-1-[4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-1H-pyrazol-3-yl]benzoic acid;Benzoic acid, 4-[5-[3,5-bis(1,1-dimethylethyl)phenyl]-1-[4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-1H-pyrazol-3-yl]-
- 中文名:
- CS-2631
- 中文别名:
- 化合物 T15811;LY2955303游离态;化合物LY2955303;4-(5-(3,5-二叔丁基苯基)-1-(4-(4-甲基哌嗪-1-羰基)苯基)-1H-吡唑-3-基)苯甲酸
- CBNumber:
- CB03312276
- 分子式:
- C36H42N4O3
- 分子量:
- 578.74
- MOL File:
- 1433497-19-8.mol
|
|
|
CS-2631化学性质
-
沸点:
-
721.9±60.0 °C(Predicted)
-
|
-
密度:
-
1.15±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
2-8°C
-
|
-
溶解度:
-
Chloroform: 25 mg/ml
-
|
-
形态:
-
A crystalline solid
-
|
-
酸度系数(pKa):
-
3.84±0.10(Predicted)
-
|
CS-2631性质、用途与生产工艺
LY2955303 是一种有效且有选择性的视黄酸受体 γ (RARγ) 的拮抗剂,其 Ki 值为 1.09 nM。
LY2955303 is tested and observed that the binding K
i
s for RARα, RARβ and RARγ are >1700, >2980 and 1.09 nM, respectively. The functional K
i
for RARγ is 7.1±4.9 nM.
A single oral dose of LY2955303 demonstrates a dose responsive effect whereby the rat reduces differential weight bearing (ED
50
=0.72 mg/kg).
CS-2631
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-107765 | CS-2631 LY2955303 | 1433497-19-8 | 5mg | 1000元 |
2024/04/30 | HY-107765 | CS-2631 LY2955303 | 1433497-19-8 | 10mM * 1mLin DMSO | 1273元 |
1433497-19-8, CS-2631 相关搜索:
- C36H42N4O3
- 化合物LY2955303
- 4-(5-(3,5-二叔丁基苯基)-1-(4-(4-甲基哌嗪-1-羰基)苯基)-1H-吡唑-3-基)苯甲酸
- 化合物 T15811
- LY2955303游离态
- 1433497-19-8
- inhibit,LY 2955303,Autophagy,LY-2955303,Retinoic acid receptors,RAR/RXR,Inhibitor,LY2955303,Retinoid X receptors
- LY2955303 >=98% (HPLC)
- Benzoic acid, 4-[5-[3,5-bis(1,1-dimethylethyl)phenyl]-1-[4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-1H-pyrazol-3-yl]-
- LY2955303; LY-2955303; LY 2955303
- CS-2631
- 4-[5-[3,5-Bis(1,1-dimethylethyl)phenyl]-1-[4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-1H-pyrazol-3-yl]benzoic acid
- LY2955303